Dr. Timothy E. Byun
Claim this profileSaint Joseph Hospital - Orange
Expert in Cancer
Studies Lung Cancer
30 reported clinical trials
84 drugs studied
About Timothy E. Byun
Education:
- Earned his MD from the University of California, Irvine School of Medicine.
- Completed residency in Internal Medicine at the University of California, Irvine Medical Center.
- Undertook a fellowship in Hematology and Oncology at the City of Hope National Medical Center.
Experience:
- Specializes in Hematology and Oncology at Saint Joseph Hospital - Orange.
Area of expertise
1Cancer
Global LeaderStage IV
HER2 positive
ER positive
2Lung Cancer
Stage IV
Stage III
Stage II
Affiliated Hospitals
Clinical Trials Timothy E. Byun is currently running
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
Selumetinib + Olaparib
for Ovarian and Endometrial Cancer
This phase II ComboMATCH treatment trial compares selumetinib plus olaparib to selumetinib alone in women with endometrial or ovarian (fallopian tube and primary peritoneal) cancer that has come back (recurrent) or that remains despite treatment (persistent) and harbors a mutation in the RAS pathway. Selumetinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Olaparib is an inhibitor of PARP, an enzyme that helps repair deoxyribonucleic acid (DNA) when it becomes damaged. Blocking PARP may help keep tumor cells from repairing their damaged DNA, causing them to die. PARP inhibitors are a type of targeted therapy. The addition of olaparib to selumetinib could increase the percentage of tumors that shrink as well as lengthen the time that the tumors remain stable (without progression) as compared to selumetinib alone.
Recruiting1 award Phase 2
More about Timothy E. Byun
Clinical Trial Related7 years of experience running clinical trials · Led 30 trials as a Principal Investigator · 19 Active Clinical TrialsTreatments Timothy E. Byun has experience with
- Pembrolizumab
- Oxaliplatin
- Paclitaxel
- Fluorouracil
- Nivolumab
- Ipatasertib
Breakdown of trials Timothy E. Byun has run
Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Breast Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Timothy E. Byun specialize in?
Timothy E. Byun focuses on Cancer and Lung Cancer. In particular, much of their work with Cancer has involved Stage IV patients, or patients who are HER2 positive.
Is Timothy E. Byun currently recruiting for clinical trials?
Yes, Timothy E. Byun is currently recruiting for 19 clinical trials in Orange California. If you're interested in participating, you should apply.
Are there any treatments that Timothy E. Byun has studied deeply?
Yes, Timothy E. Byun has studied treatments such as Pembrolizumab, Oxaliplatin, Paclitaxel.
What is the best way to schedule an appointment with Timothy E. Byun?
Apply for one of the trials that Timothy E. Byun is conducting.
What is the office address of Timothy E. Byun?
The office of Timothy E. Byun is located at: Saint Joseph Hospital - Orange, Orange, California 92868 United States. This is the address for their practice at the Saint Joseph Hospital - Orange.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.